http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2363475-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d877ff9c1697920f3cd5d5d7f58cd33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c2d5cb6d36cab685825b8d56f3837cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95e1c68c560b26b1e0a2f83ae4a04798
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75aec5ae1a02cd5610ce23b733290a14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fee26289ccf02113aa4060811373e3f4
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
filingDate 2007-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_729146e59c1c75eaaa361c7affefc7a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7317c8dc29e90d39b6fbee61c5c22bd
publicationDate 2009-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2363475-C2
titleOfInvention Antituberculous tablet
abstract FIELD: medicine. n SUBSTANCE: invention concerns medicine, namely to the agents possessing antituberculous action and used in phthisiology. The tablet contains 1-isonicotinyl-2-glucosylhydrazone dihydrate (isoglucosyl), hydroxypropylmethylcellulose or methylcellulose and calcium stearate. The tablet can be covered by a cover. The invention provides high therapeutic efficiency and hypotoxicity of the new agent in comparison with known antituberculous forms of Isoniaside and rifampicin. n EFFECT: provision of high therapeutic efficiency and hypotoxicity of the new agent in comparison with known antituberculous forms of Isoniaside and rifampicin. n 2 cl, 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012044140-A1
priorityDate 2007-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431847471
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467062113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448178750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135900090

Total number of triples: 39.